These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 35328463)

  • 1. Male Infertility in the XXI Century: Are Obesogens to Blame?
    Sousa ACA; Alves MG; Oliveira PF; Silva BM; Rato L
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesogens and male fertility.
    Cardoso AM; Alves MG; Mathur PP; Oliveira PF; Cavaco JE; Rato L
    Obes Rev; 2017 Jan; 18(1):109-125. PubMed ID: 27776203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Endocrine-Disrupting Chemicals in Male Fertility: Focus on the Action of Obesogens.
    Rato L; Sousa ACA
    J Xenobiot; 2021 Nov; 11(4):163-196. PubMed ID: 34940512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesogens and Obesity: State-of-the-Science and Future Directions Summary from a Healthy Environment and Endocrine Disruptors Strategies Workshop.
    Heindel JJ; Alvarez JA; Atlas E; Cave MC; Chatzi VL; Collier D; Corkey B; Fischer D; Goran MI; Howard S; Kahan S; Kayhoe M; Koliwad S; Kotz CM; La Merrill M; Lobstein T; Lumeng C; Ludwig DS; Lustig RH; Myers P; Nadal A; Trasande L; Redman LM; Rodeheffer MS; Sargis RM; Stephens JM; Ziegler TR; Blumberg B
    Am J Clin Nutr; 2023 Jul; 118(1):329-337. PubMed ID: 37230178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesogens: How They Are Identified and Molecular Mechanisms Underlying Their Action.
    Mohajer N; Du CY; Checkcinco C; Blumberg B
    Front Endocrinol (Lausanne); 2021; 12():780888. PubMed ID: 34899613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine disruptors and estrogenic effects on male reproductive axis.
    Sikka SC; Wang R
    Asian J Androl; 2008 Jan; 10(1):134-45. PubMed ID: 18087652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenerational effects of obesogens.
    Lee MK; Blumberg B
    Basic Clin Pharmacol Toxicol; 2019 Aug; 125 Suppl 3(Suppl 3):44-57. PubMed ID: 30801972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesogens in Foods.
    Kladnicka I; Bludovska M; Plavinova I; Muller L; Mullerova D
    Biomolecules; 2022 May; 12(5):. PubMed ID: 35625608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Obesogens in the Pathogenesis of Obesity.
    Shahnazaryan U; Wójcik M; Bednarczuk T; Kuryłowicz A
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31438630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of the obesogen tributyltin on the metabolism of Sertoli cells cultured ex vivo.
    Cardoso AM; Alves MG; Sousa AC; Jarak I; Carvalho RA; Oliveira PF; Cavaco JE; Rato L
    Arch Toxicol; 2018 Feb; 92(2):601-610. PubMed ID: 28993852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesogenic endocrine disruptors and obesity: myths and truths.
    Muscogiuri G; Barrea L; Laudisio D; Savastano S; Colao A
    Arch Toxicol; 2017 Nov; 91(11):3469-3475. PubMed ID: 28975368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental endocrine disruptors and obesity.
    Karoutsou E; Polymeris A
    Endocr Regul; 2012 Jan; 46(1):37-46. PubMed ID: 22329821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endocrine disruptors and obesity: obesogens].
    García-Mayor RV; Larrañaga Vidal A; Docet Caamaño MF; Lafuente Giménez A
    Endocrinol Nutr; 2012 Apr; 59(4):261-7. PubMed ID: 22300604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Pharmaceutical Substances with Obesogenic Activity on Male Reproductive Health.
    Mascarenhas C; Sousa ACA; Rato L
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new kids on the block: Emerging obesogens.
    Chamorro-Garcia R; Veiga-Lopez A
    Adv Pharmacol; 2021; 92():457-484. PubMed ID: 34452694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Obesogens in the XXI century: Emerging health challenges.
    Sousa ACA; Malarvannan G; Isobe T; Rato L
    Front Endocrinol (Lausanne); 2022; 13():999908. PubMed ID: 36004345
    [No Abstract]   [Full Text] [Related]  

  • 17. Is Technical-Grade Chlordane an Obesogen?
    Silva JF; Moreira BP; Rato L; de Lourdes Pereira M; Oliveira PF; Alves MG
    Curr Med Chem; 2021; 28(3):548-568. PubMed ID: 31965937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine disruptors and obesity.
    Heindel JJ; Newbold R; Schug TT
    Nat Rev Endocrinol; 2015 Nov; 11(11):653-61. PubMed ID: 26391979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organotins: a review of their reproductive toxicity, biochemistry, and environmental fate.
    Graceli JB; Sena GC; Lopes PF; Zamprogno GC; da Costa MB; Godoi AF; Dos Santos DM; de Marchi MR; Dos Santos Fernandez MA
    Reprod Toxicol; 2013 Apr; 36():40-52. PubMed ID: 23228341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine Disruptors and Obesity.
    Darbre PD
    Curr Obes Rep; 2017 Mar; 6(1):18-27. PubMed ID: 28205155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.